A CTX-M extended-spectrum β-lactamase in Pseudomonas aeruginosa and Stenotrophomonas maltophilia [2]

Journal of Medical Microbiology

Volumn 55, Issue 11, 2006, Pages 1607-1608

  Al Naiemi, Nashwan ^a   Duim, Birgitta ^a   Bart, Aldert ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; BACTERIAL ENZYME; CEFEPIME; CEFOTAXIME; CEFPODOXIME; CEFTAZIDIME; CEPHALOSPORIN DERIVATIVE; EXTENDED SPECTRUM BETA LACTAMASE;

ANTIBIOTIC RESISTANCE; BACTERIAL INFECTION; ENZYME ANALYSIS; HOSPITAL INFECTION; LETTER; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; STENOTROPHOMONAS MALTOPHILIA; STRAIN IDENTIFICATION;

ADULT; BETA-LACTAMASES; DNA, BACTERIAL; GRAM-NEGATIVE BACTERIAL INFECTIONS; HUMANS; INFANT, NEWBORN; MALE; MICROBIAL SENSITIVITY TESTS; POLYMERASE CHAIN REACTION; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; STENOTROPHOMONAS MALTOPHILIA;

EID: 33750810241     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/jmm.0.46704-0     Document Type: Letter

References (16)

1. al Naiemi, N. A., Duim, B., Savelkoul, P. H. M., Spanjaard, L., de Jonge, E., Bart, A., Vandenbroucke-Grauls, C. M. & de Jong, M. D. (2005), Widespread transfer of resistance genes between bacterial species in an intensive care unit: implications for hospital epidemiology. J Clin Microbiol 43, 4862-4864.
2. Bonnet, R. (2004). Growing group of extended-spectrum β-lactamases: the CTX-M enzymes. Antimicrob Agents Chemother 48, 1-14.
3. Bonnet, R., Dutour, C., Sampaio, J. L. M., Chanal, C., Sirot, D., Labia, R., De Champs, C. & Sirot, J. (2001). Novel cefotaximase (CTX-M-16) with increased catalytic efficiency due to substitution Asp-240→Gly. Antimicrob Agents Chemother 45, 2269-2275.
4. Bradford, P. A. (2001). Extended-spectrum β-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat. Clin Microbiol Rev 14, 933-951.
5. CTX-M genes. J Antimicrob Chemother 57, 14-23.
6. Livermore, D. M. (1991). β-Lactamases of Pseudomonas aeruginosa. Antibiot Chemother 44, 215-220.
7. Matsumoto, Y., Ikeda, F., Kamimura, T., Yokota, Y. & Mine, Y. (1988). Novel plasmid-mediated β-lactamase from Escherichia coli that inactivates oxyiminocephalosporins. Antimicrob Agents Chemother 32, 1243-1246.
8. Nagano, N., Nagano, Y., Cordevant, C., Shibata, N. & Arakawa, Y. (2004). Nosocomial transmission of CTX-M-2 β-lactamase-producing Acinetobacter baumannii in a neurosurgery ward. J Clin Microbiol 42, 3978-3984.
9. NCCLS (2005). Performance standards for antimicrobial susceptibility testing; 15th informational supplement (M100-S15). Wayne, PA: National Committee for Clinical Laboratory Standards.
10. Paterson, D. L. & Bonomo, R. A. (2005). Extended-spectrum β-lactamases: a clinical update. Clin Microbiol Rev 18, 657-686.
11. Pitout, J. D. D., Nordmann, P., Laupland, K. B. & Poirel, L. (2005). Emergence of Enterobacteriaceae producing extended-spectrum β-lactamases (ESBLs) in the community. J Antimicrob Chemother 56, 52-59.
12. Ramadan, M. A., Tawfik, A. F. & Shibl, A. M. (1995). Effect of β-lactamase expression on susceptibility of local isolates of Enterobacter cloacae, Serratia marcescens and Pseudomonas aeruginosa to β-lactam antibiotics. Chemotherapy 41, 193-199.
13. Relman, D. A., Schmidt, T. M., MacDermott, R. P. & Falkow, S. (1992). Identification of the uncultured bacillus of Whipple's disease. N Engl J Med 327, 293-301.
14. Sirot, D., Sirot, J., Labia, R., Morand, A., Courvalin, P., Darfeuille-Michaud, A., Perroux, R. & Cluzel, R. (1987). Transferable resistance to third-generation cephalosporins in clinical isolates of Klebsiella pneumoniae: identification of CTX-1, a novel β-lactamase. J Antimicrob Chemother 20, 323-334.
15. Walsh, T. R., MacGowan, A. P. & Bennett, P. M. (1997). Sequence analysis and enzyme kinetics of the L2 serine beta-lactamase from Stenotrophomonas maltophilia. Antimicrob Agents Chemother 41, 1460-1464.
16. Weldhagen, G. F., Poirel, L. & Nordmann, P. (2003). Ambler class A extended-spectrum β-lactamases in Pseudomonas aeruginosa: novel developments and clinical impact. Antimicrob Agents Chemother 47, 2385-2392.